Iomai Reports 'Going Concern' Qualification in 10-K

Saturday, March 29, 2008 General News
Email Print This Page Comment
Font : A-A+

GAITHERSBURG, Md., March 28 Iomai Corporation(Nasdaq: IOMI) today announced, in compliance with NASDAQ marketplace rules,that the independent audit report included in the Company's Annual Report onForm 10-K filed with the Securities and Exchange Commission on March 27, 2008for the fiscal year ended December 31, 2007 contained a "going concern"qualification. This disclosure is required under NASDAQ marketplace rules anddoes not represent any change to the Company's Annual Report on Form 10-K forthe year ended December 31, 2007 and filed on March 27, 2008 with the SEC.

ABOUT IOMAI CORPORATION

Iomai Corporation discovers and develops vaccines and immune systemstimulants, delivered via a novel, needle-free technology calledtranscutaneous immunization (TCI). TCI, discovered by researchers at theWalter Reed Army Institute of Research, taps into the unique benefits of amajor group of antigen-presenting cells found in the outer layers of the skin(Langerhans cells) to generate an enhanced immune response. Iomai isleveraging TCI to enhance the efficacy of existing vaccines, develop newvaccines that are viable only through transcutaneous administration and expandthe global vaccine market. Iomai currently has four product candidates indevelopment: three targeting influenza and pandemic flu and one to preventtravelers' diarrhea. For more information on Iomai, please visithttp://www.iomai.com.

SOURCE Iomai Corporation


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook